Related Experiment Video
Updated: Jun 25, 2025

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.3K
A telemonitoring intervention design for patients with poorly controlled type 2 diabetes: protocol for a feasibility
Sisse H Laursen1,2,3, Iben Engelbrecht Giese4, Flemming W Udsen4
1Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. sih@hst.aau.dk.
Pilot and Feasibility Studies
|May 22, 2024
Summary
This study evaluates two telemonitoring designs to improve glycemic control in type 2 diabetes (T2D). Findings will guide future telemedicine interventions for better patient outcomes and user acceptance.
Area of Science:
- Diabetes Management
- Telemedicine and Health Technology
- Clinical Feasibility Studies
Background:
- Optimal glycemic control in type 2 diabetes (T2D) presents significant challenges.
- Telemedicine, particularly with telemonitoring, shows promise for supporting T2D management.
- The ideal telemonitoring design for T2D patients requires further clarification.
Purpose of the Study:
- To assess the feasibility of two distinct telemonitoring designs for individuals with non-insulin-dependent T2D.
- To identify the optimal telemonitoring intervention for future large-scale randomized controlled trials.
- To gather insights into user and clinician experiences and acceptance of different telemonitoring approaches.
Main Methods:
- A 3-month randomized feasibility study involving 60 participants across four municipalities in North Denmark.
- Comparison of two telemonitoring interventions: one with self-monitoring of blood glucose (SMBG), sleep, and mental health monitoring; the second adding blood pressure and activity monitoring.
- Inclusion of qualitative interviews with participants and clinicians, alongside cost analysis of interventions.
Main Results:
- Feasibility data on two telemonitoring designs will be collected.
- Qualitative insights into participant and clinician experiences will be gathered.
- Cost differences between the two intervention designs will be investigated.
Conclusions:
- Telemonitoring holds potential for improving glycemic control in diabetes, but optimal intervention design is still under investigation.
- Results are expected to inform the design of future telemonitoring studies in T2D.
- A well-designed telemonitoring intervention is crucial for user acceptance and enhanced patient outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
265
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K

